Quantcast

Latest Enbrel Stories

2014-07-16 08:28:14

Company Advances Development as Part of Collaboration with Baxter International's Biopharmaceutical Business REDWOOD CITY, Calif., July 16, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, a proposed biosimilar of etanercept (Enbrel®), in chronic plaque psoriasis (the RaPsOdy trial). This announcement follows the recent initiation of a Phase 3 trial of CHS-0214 in rheumatoid arthritis. The Phase 3 psoriasis trial is a 48-week,...

2013-12-10 23:20:12

Reportbuyer.com just published a new market research report: Biosimilar Opportunities in an Evolving Market. London (PRWEB) December 10, 2013 Biosimilars: another milestone passed At the end of June 2013, the European Medicines Agency’s Committee for Medical Products for Human Use issued a positive opinion for the first biosimilar version of Johnson & Johnson’s infliximab for the treatment of rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis. For the two...

2013-10-23 23:32:32

The process involves a novel physical therapy utilizing stretching, massage and strength training coupled with a neuro anti-inflammatory agent. Reductions in spasticity and recovery of feeling are generally observed on the first day and continue to build with continued treatment according to Neurological Wellness Center physicians. (PRWEB) October 23, 2013 Phillip Koss, owner of http://www.strechforlife.com/ is quick to point out that this process is no panacea. A severely disabled...

2013-10-16 23:31:55

Neurological Wellness Center physicians encourage persons with mild to moderate Alzheimer’s disease to participate. Participants will be given weekly injections plus nutritional supplements that may suppress inflammatory processes associated with Alzheimer’s disease. (PRWEB) October 16, 2013 Many people receiving this treatment report a clearing of brain fog within minutes of receiving this injection. Pre-treatment and post-treatment cognitive function testing is utilized to document...

2013-10-02 23:33:35

Pharmaceutical research companies are now investigating or developing 81 Alzheimer’s drugs.* A blockbuster treatment for moderate to severe Alzheimer’s is still more than ten years away according to Rolando Hernandez neurosurgeon for Neurological Wellness Center. (PRWEB) October 02, 2013 Pharmaceutical research has banked heavily on the beta amyloid hypothesis. The recent failures of bapineuzumab and solanezumab in phase III clinical trials has forced researchers to question weather...

2013-09-25 23:37:58

The efficacy of the stretching massage that releases spastic muscles and restores feeling and function is substantially enhanced with perispinally administered etanercept. (PRWEB) September 25, 2013 Since 2009, Stretch for Life has been enabling persons with stroke and traumatic brain injury (TBI) to regain feeling and function. The process involves full body stretching, massage, acupressure, strength training coupled with mental focus, breathing and visualization to eliminate spasticity...

2013-09-10 23:29:28

American physicians have been reversing and stabilizing Alzheimer’s disease since 2005. NWC physicians have been teaching Enbrel injection procedure since 2010 and call upon Maxine Waters to facilitate the widespread implementation of this treatment. (PRWEB) September 10, 2013 The history of medicine is replete with examples of breakthrough treatments languishing, broadly under-utilized for decades. Consider the local anesthetic procaine, which is still in use today. Procaine was...

2013-09-04 23:25:54

NWC physicians respond to recent article: Traumatic Brain Injury Research Good for the Troops or Just the PhDs? * (PRWEB) September 04, 2013 In a study commissioned by the Veterans Administration, the Rand Corporation interviewed thousands of veterans from Iraq and Afghanistan and estimated 18% suffer from PTSD and 19% suffer from traumatic brain injury (TBI). Yet according to the Defense and Brain Injury Center, 266,810 soldiers were diagnosed with PTSD from 2000 through 2012; yet only...

2013-08-28 23:27:00

NWC Physicians praise Elan Pharmaceuticals for developing a vaccine that removes the buildup of beta-amyloid and plaque in the brain, restoring function without side effects in an 80 patient trial according to a recent report published in the Daily Mail*. (PRWEB) August 28, 2013 Research teams at the University of Edinburgh Medical School and University of Toronto Medical School report; "Not only were we able to clean up the brain tissue, but we also prevented the behavioral...

2013-08-14 23:25:12

Neurological Wellness Center physicians respond to a recent survey finding 37% of stroke survivors develop depression and report the alleviation of depression is a predictable outcome of perispinally administered Enbrel treatment for stroke. (PRWEB) August 14, 2013 An estimated 700,000 people have a stroke in the United States each year, and approximately 37% of stroke survivors develop depression within 2 years according to survey published in NewsFix*. Several studies have shown that...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.